Sheila Abril, member of GT1, attended the EFMC-ACSMEDI MedChem Frontiers 2019 congress held in Krakow (Poland), on June 10-13. The American Chemical Society and the European Federation of Medical Chemistry organize this bi-annual event that brings together 300 participants from the Drug R&D academic and industrial sectors (medical chemists, bioinformatics, biologists, pharmacologists, toxicologists, etc.). Sheila had the opportunity to present her work related to multitarget ligands, presenting a poster entitled “Multitarget directed ligands to treat Alzheimer’s Disease: NRF2 inducers, cholinergic neurotransmission modulators and free radical scavengers”.
Congratulations for your work!
